CAV1 and metabolic dysfunction-associated steatotic liver disease: Cav-1 down-regulation in hepatocytes inhibited the process that converse the Fe2+ to Fe3+ through the regulation of the FTL/FTH signaling pathway, leading to the accumulation of Fe2+ in hepatocytes which aggravated the oxidative stress induced by Fe2+ and ultimately accelerated the progression of NAFLD.